Protagenic Therapeutics, Inc.\new Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Protagenic Therapeutics, Inc.\new (PTIX) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $83.67 thousand as of 2020-12-31, per its 10-K filed 2022-04-07.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2022-04-07
- 2020-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $83.67K.
- 2020-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $190.31K.
- 2020-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $295.03K.
- 2020-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $271.47K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2020-12-31 | $83.67K 10-K · filed 2022-04-07 |
| 2020-09-30 | $190.31K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $295.03K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $271.47K 10-Q · filed 2020-06-18 |
| 2019-12-31 | $332.22K 10-K · filed 2021-03-25 |
| 2019-09-30 | $334.97K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $400.18K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $626.68K 10-Q · filed 2019-05-16 |
| 2018-12-31 | $676.08K 10-K · filed 2021-03-25 |
| 2018-09-30 | $408.09K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $407.62K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $419.68K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $425.84K 10-K · filed 2020-04-29 |
| 2016-12-31 | $516.87K 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |